Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Elanco Animal Health stock

ELAN
US28414H1032
A2N6BH

Price

11.31
Today +/-
+0.13
Today %
+1.25 %

Elanco Animal Health stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Elanco Animal Health stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Elanco Animal Health stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Elanco Animal Health stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Elanco Animal Health's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Elanco Animal Health Stock Price History

DateElanco Animal Health Price
3/2/202511.31 undefined
2/27/202511.17 undefined
2/26/202510.92 undefined
2/25/202511.13 undefined
2/24/202510.70 undefined
2/23/202511.11 undefined
2/20/202511.02 undefined
2/19/202511.13 undefined
2/18/202511.24 undefined
2/17/202511.32 undefined
2/13/202511.25 undefined
2/12/202511.66 undefined
2/11/202511.38 undefined
2/10/202511.41 undefined
2/9/202511.48 undefined
2/6/202511.52 undefined
2/5/202511.97 undefined
2/4/202512.03 undefined
2/3/202511.51 undefined
2/2/202511.72 undefined

Elanco Animal Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Elanco Animal Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Elanco Animal Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Elanco Animal Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Elanco Animal Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Elanco Animal Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Elanco Animal Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Elanco Animal Health’s growth potential.

Elanco Animal Health Revenue, EBIT and net profit per share

DateElanco Animal Health RevenueElanco Animal Health EBITElanco Animal Health Net Income
2030e5.57 B undefined0 undefined831.99 M undefined
2029e5.37 B undefined1.14 B undefined756.36 M undefined
2028e5.32 B undefined1.1 B undefined729.88 M undefined
2027e5.11 B undefined1.04 B undefined654.25 M undefined
2026e4.83 B undefined787 M undefined529.52 M undefined
2025e4.62 B undefined694.76 M undefined454.7 M undefined
2024e4.51 B undefined770.08 M undefined462.23 M undefined
20234.42 B undefined326 M undefined-1.23 B undefined
20224.41 B undefined384 M undefined-78 M undefined
20214.76 B undefined304 M undefined-483 M undefined
20203.27 B undefined-82 M undefined-574 M undefined
20193.07 B undefined370 M undefined67.9 M undefined
20183.07 B undefined313.8 M undefined86.5 M undefined
20172.89 B undefined142.4 M undefined-310.7 M undefined
20162.91 B undefined283.2 M undefined-47.9 M undefined
20152.91 B undefined5.4 M undefined-210.8 M undefined
20142.07 B undefined306.1 M undefined164.9 M undefined
20131.93 B undefined309.9 M undefined191 M undefined

Elanco Animal Health Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e2030e
1.932.072.912.912.893.073.073.274.764.414.424.514.624.835.115.325.375.57
-7.1640.800.14-0.826.130.166.5145.64-7.410.142.172.444.395.784.290.863.80
56.3354.8447.2751.6348.2948.7052.1049.0455.2556.6356.2855.0953.7751.5148.7046.6946.2944.60
1.091.131.381.51.41.491.61.62.632.52.490000000
191164-210-47-3108667-574-483-78-1,231462454529654729756831
--14.14-228.05-77.62559.57-127.74-22.09-956.72-15.85-83.851,478.21-137.53-1.7316.5223.6311.473.709.92
356.2356.2356.2356.2356.2365.6370.3441.4487.2488.3492.30000000
------------------
Details

Keystats

ⓘ

Revenue and Growth

The Elanco Animal Health Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Elanco Animal Health is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20162017201820192020202120222023
               
259323475334495638345352
585567652817872833797842
46355773205195205168
0.881.0611.051.581.371.541.74
18213631798267237394310
1.952.122.512.373.423.283.283.41
0.740.920.921.041.51.221.141.17
912151933222726
00000000
2.622.672.452.486.395.594.844.49
2.582.972.962.996.236.175.995.09
20424210381127204210175
6.156.826.456.6114.2813.2112.2110.96
8.18.948.968.9917.6916.4815.4914.36
               
00000000
005.45.648.658.78.748.78
7.498.040.020.08-0.48-0.95-1.06-2.29
-457-257-222-174303-209-392-266
00000000
7.037.785.25.558.487.547.296.22
228204205223501418390270
838999123181219177189
308350638448840712747744
00000000
00292555529438838
0.620.640.970.822.081.641.71.24
002.442.335.576.035.455.74
228252115101900745662567
225265231189668532390595
0.450.522.792.627.147.36.56.9
1.071.163.763.449.228.958.28.14
8.18.948.968.9917.6916.4815.4914.36
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Elanco Animal Health provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Elanco Animal Health's financial health and stability.

Assets

Elanco Animal Health's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Elanco Animal Health must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Elanco Animal Health after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Elanco Animal Health's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201520162017201820192020202120222023
-210-47-3108667-560-472-78-1,231
236254318296314516716682694
-76-5-13-600-124-154-57-80
-15-16953-29-227165-87-462-300
0.090.150.150.220.120.010.550.431.23
000000000
000000000
6155173487224-41483452271
-100-110-98-134-197-310-197-184-154
-4,995-182-964-127-234-4,779-530-179-169
-4,895-71-8667-37-4,468-3335-15
000000000
0002.49-0.123.850.18-0.5-0.08
0001.6601.22000
5.35-0.150.85-0.04-0.34.950.21-0.55-0.08
5.35-0.150.85-4.19-0.18-0.120.03-0.05-0.01
000000000
344-20164354-332160132-2937
-93.545.675.2352.826.7-351.9286268117
000000000

Elanco Animal Health stock margins

The Elanco Animal Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Elanco Animal Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Elanco Animal Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Elanco Animal Health's sales revenue. A higher gross margin percentage indicates that the Elanco Animal Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Elanco Animal Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Elanco Animal Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Elanco Animal Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Elanco Animal Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Elanco Animal Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Elanco Animal Health Margin History

Elanco Animal Health Gross marginElanco Animal Health Profit marginElanco Animal Health EBIT marginElanco Animal Health Profit margin
2030e56.28 %0 %14.93 %
2029e56.28 %21.17 %14.08 %
2028e56.28 %20.57 %13.71 %
2027e56.28 %20.45 %12.82 %
2026e56.28 %16.31 %10.97 %
2025e56.28 %15.03 %9.84 %
2024e56.28 %17.06 %10.24 %
202356.28 %7.38 %-27.87 %
202256.63 %8.71 %-1.77 %
202155.25 %6.38 %-10.14 %
202049.04 %-2.51 %-17.55 %
201952.12 %12.05 %2.21 %
201848.68 %10.23 %2.82 %
201748.29 %4.93 %-10.75 %
201651.64 %9.72 %-1.64 %
201547.28 %0.19 %-7.25 %
201454.86 %14.82 %7.98 %
201356.33 %16.07 %9.9 %

Elanco Animal Health Stock Sales Revenue, EBIT, Earnings per Share

The Elanco Animal Health earnings per share therefore indicates how much revenue Elanco Animal Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Elanco Animal Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Elanco Animal Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Elanco Animal Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Elanco Animal Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Elanco Animal Health Revenue, EBIT and net profit per share

DateElanco Animal Health Sales per ShareElanco Animal Health EBIT per shareElanco Animal Health Earnings per Share
2030e11.28 undefined0 undefined1.68 undefined
2029e10.86 undefined0 undefined1.53 undefined
2028e10.77 undefined0 undefined1.48 undefined
2027e10.33 undefined0 undefined1.32 undefined
2026e9.76 undefined0 undefined1.07 undefined
2025e9.35 undefined0 undefined0.92 undefined
2024e9.13 undefined0 undefined0.94 undefined
20238.97 undefined0.66 undefined-2.5 undefined
20229.03 undefined0.79 undefined-0.16 undefined
20219.78 undefined0.62 undefined-0.99 undefined
20207.41 undefined-0.19 undefined-1.3 undefined
20198.29 undefined1 undefined0.18 undefined
20188.39 undefined0.86 undefined0.24 undefined
20178.11 undefined0.4 undefined-0.87 undefined
20168.18 undefined0.8 undefined-0.13 undefined
20158.17 undefined0.02 undefined-0.59 undefined
20145.8 undefined0.86 undefined0.46 undefined
20135.41 undefined0.87 undefined0.54 undefined

Elanco Animal Health business model

The company Elanco Animal Health Inc was founded in 1954 in Greenfield, Indiana, USA, as a division of Eli Lilly and Company. Since 2018, the company has been an independent entity and has its headquarters in Indianapolis. The business model of Elanco Animal Health is to develop and market transformative products and services that improve the health and well-being of animals. The company has four main divisions: cattle, swine, poultry, and pets. In the cattle division, Elanco Animal Health offers products that support the health and growth of cattle. These include antibiotics, anti-inflammatory medications, and hormones. The company also offers products that can increase milk production in dairy cows. The swine division of Elanco Animal Health offers products that protect pigs against diseases and promote growth. Additionally, the company provides services such as consulting and training to help pig farmers run their operations more effectively. In the poultry division, Elanco Animal Health offers products that promote the health and growth of poultry. These include antibiotics, vaccines, and other medications. The company also offers consulting services to help poultry farmers improve their operations. In the pet division, Elanco Animal Health offers a wide range of products for pets, including vaccines, flea and tick treatments, supplements, and pain relief products. The company works closely with veterinarians to ensure that their products meet the needs of pets. Elanco Animal Health is also a leader in the development of technologies that aim to improve the health and well-being of animals. The company has developed a range of platforms that can collect and analyze data on animal health and behavior. This allows animal owners to run their operations more effectively and provides veterinarians with better diagnosis and treatment of diseases. Overall, Elanco Animal Health is an important player in the veterinary industry, focusing on developing transformative products and services that improve the health and well-being of animals. The company has developed a wide range of products and services for cattle, swine, poultry, and pets, and works closely with veterinarians and animal owners to ensure that their products meet the needs of animals. Elanco Animal Health is one of the most popular companies on Eulerpool.com.

Elanco Animal Health SWOT Analysis

Strengths

Elanco Animal Health Inc has established itself as a leading company in the animal health industry, known for its expertise and innovation.

The company offers a diverse portfolio of products and services catering to various animal species, providing a strong foundation for growth.

Elanco has a wide distribution network and strong relationships with veterinarians and other suppliers, enabling efficient delivery of its products and facilitating customer satisfaction.

Weaknesses

One weakness of Elanco Animal Health Inc is its dependence on a few key product lines, which may expose the company to risks if there are any issues with those products.

The company also faces intense competition from other players in the animal health industry, which may impact its market share and profitability.

Elanco's global presence is not as extensive as some of its competitors, limiting its reach in certain markets.

Opportunities

The growing worldwide demand for animal protein presents a significant opportunity for Elanco to expand its product offerings and capture a larger market share.

The increasing trend of pet ownership and humanization of pets provides an opportunity for the company to develop and market specialized products catering to this growing market segment.

Expanding into emerging markets, where the demand for animal health products is rising, can further drive the company's growth and revenue.

Threats

Regulatory changes and stricter compliance requirements in the animal health industry pose a threat to Elanco, as non-compliance may lead to legal and financial consequences.

An economic downturn or recession can potentially impact consumer spending on animal health products, affecting the company's sales and profitability.

The emergence of alternative therapies and treatments, such as naturopathy, may pose a threat to traditional pharmaceutical products offered by Elanco.

Elanco Animal Health Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Elanco Animal Health Revenue by Segment

Segmente202320222021202020192018
Farm Animal2.27 B USD-----
Pet Health2.1 B USD-----
Food Animal Ruminants Swine-----1.17 B USD
Companion Animal Disease Prevention-----804.6 M USD
Food Animal Future Protein & Health-----711.2 M USD
Companion Animal Therapeutics-----283.1 M USD
Other-----93.9 M USD
Contract Manufacturing42 M USD-----

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Elanco Animal Health Revenue by Segment

Segmente202320222021202020192018
Farm Animal-2.22 B USD2.33 B USD---
Pet Health-2.14 B USD2.35 B USD---
Food Animal Ruminants Swine----1.11 B USD-
Farm Animal Ruminants & Swine---1.1 B USD--
Pet Health Disease Prevention---992.7 M USD--
Companion Animal Disease Prevention----787.9 M USD-
Food Animal Future Protein & Health----745.1 M USD-
Farm Animal Future Protein & Health---734.1 M USD--
Pet Health Therapeutics---365.8 M USD--
Companion Animal Therapeutics----348 M USD-
Strategic Exits---80.2 M USD79.7 M USD-
Contract Manufacturing-54 M USD82 M USD---

Elanco Animal Health Revenue by Region

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Elanco Animal Health Revenue by Segment

DateInternationalUnited States
20232.43 B USD1.98 B USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Elanco Animal Health Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Elanco Animal Health historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Elanco Animal Health shares outstanding

The number of shares was Elanco Animal Health in 2024 — This indicates how many shares 492.3 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Elanco Animal Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Elanco Animal Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Elanco Animal Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Elanco Animal Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Elanco Animal Health.

Elanco Animal Health latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.12 0.13  (7.88 %)2024 Q3
6/30/20240.25 0.3  (22.25 %)2024 Q2
3/31/20240.27 0.34  (26.39 %)2024 Q1
12/31/20230.11 0.08  (-25.99 %)2023 Q4
9/30/20230.12 0.18  (48.39 %)2023 Q3
6/30/20230.05 0.18  (269.61 %)2023 Q2
3/31/20230.29 0.45  (53.01 %)2023 Q1
12/31/20220.13 0.19  (45.15 %)2022 Q4
9/30/20220.16 0.2  (23.3 %)2022 Q3
6/30/20220.26 0.36  (38.94 %)2022 Q2
1
2
3

Eulerpool ESG Scorecard© for the Elanco Animal Health stock

Eulerpool World ESG Rating (EESG©)

66/ 100

🌱 Environment

71

👫 Social

88

🏛️ Governance

40

Environment

Scope 1 - Direct Emissions
146,844
Scope 2 - Indirect emissions from purchased energy
208,259
Scope 3 - Indirect emissions within the value chain
690,127
Total CO₂ emissions
355,103
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees45.08
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Elanco Animal Health shareholders

%
Name
Stocks
Change
Date
16.82627 % Dodge & Cox83,180,666-134,88412/31/2024
10.34999 % PRIMECAP Management Company51,165,165-1,410,33712/31/2024
9.82698 % The Vanguard Group, Inc.48,579,653-248,06812/31/2024
5.76738 % Fidelity Management & Research Company LLC28,511,03725,442,76612/31/2024
4.18309 % BlackRock Institutional Trust Company, N.A.20,679,088231,83812/31/2024
4.13364 % Black Creek Investment Management, Inc.20,434,653-865,55712/31/2024
3.62112 % Dimensional Fund Advisors, L.P.17,900,9871,074,27412/31/2024
3.17401 % T. Rowe Price Investment Management, Inc.15,690,736-5,352,07012/31/2024
2.49959 % Shapiro Capital Management LLC12,356,702862,90012/31/2024
2.43397 % Magnetar Capital Partners LP12,032,3251,454,08212/31/2024
1
2
3
4
5
...
10

Elanco Animal Health Executives and Management Board

Mr. Jeffrey Simmons

(55)
Elanco Animal Health President, Chief Executive Officer, Director (since 2018)
Compensation 12.71 M

Mr. Todd Young

(51)
Elanco Animal Health Chief Financial Officer, Executive Vice President
Compensation 3.65 M

Mr. David Kinard

(56)
Elanco Animal Health Executive Vice President, Human Resources, Corporate Communications and Administration
Compensation 2.85 M

Mr. David Urbanek

(56)
Elanco Animal Health Executive Vice President - Manufacturing and Quality
Compensation 2.84 M

Dr. Ellen de Brabander

(60)
Elanco Animal Health Executive Vice President - Innovation and Regulatory and Business Development
Compensation 2.81 M
1
2
3
4
...
5

Elanco Animal Health Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Eden Research Stock
Eden Research
SupplierCustomer 0,470,710,750,880,49
Covetrus Inc Stock
Covetrus Inc
SupplierCustomer0,790,010,280,520,810,44
Paul Mueller Stock
Paul Mueller
SupplierCustomer0,770,38-0,250,12-0,51
Pacira Biosciences Stock
Pacira Biosciences
SupplierCustomer0,700,850,80-0,10-0,58-0,17
WooGene B&G Stock
WooGene B&G
SupplierCustomer0,690,72-0,24-0,240,590,03
Tarsus Pharmaceuticals Stock
Tarsus Pharmaceuticals
SupplierCustomer0,530,580,810,830,83
RaQualia Pharma Stock
RaQualia Pharma
SupplierCustomer0,430,500,500,400,620,32
Kindred Biosciences, Inc. Stock
Kindred Biosciences, Inc.
SupplierCustomer0,23-0,25-0,35-0,48-0,67
AmerisourceBergen Stock
AmerisourceBergen
SupplierCustomer0,19-0,35-0,17-0,57-0,81-0,24
Novozymes B Stock
Novozymes B
SupplierCustomer-0,140,51-0,200,390,320,23
1

Most common questions regarding Elanco Animal Health

What values and corporate philosophy does Elanco Animal Health represent?

Elanco Animal Health Inc represents a strong commitment to improving animal health and welfare. Their corporate philosophy is rooted in the belief that healthy animals contribute to a better world for both animals and humans. They strive to deliver innovative solutions and products that address the diverse needs of animals, including their nutrition, health, and well-being. Elanco Animal Health Inc is dedicated to ensuring the responsible and ethical use of their products, while providing exceptional value to their customers. They aim to foster strong partnerships within the animal health industry and continuously work towards advancements in animal care and sustainability.

In which countries and regions is Elanco Animal Health primarily present?

Elanco Animal Health Inc is primarily present in multiple countries and regions worldwide. As a global company, Elanco operates in various parts of North America, including the United States and Canada. It also maintains a significant presence in Europe, with operations in several countries such as Germany, France, Spain, Italy, and the United Kingdom. Additionally, Elanco has a strong foothold in the Asia-Pacific region, with a focus on countries like China, Japan, Australia, and India. The company's broad international presence allows Elanco Animal Health Inc to cater to the diverse needs of animal health across different markets, showcasing its commitment to global growth and innovation.

What significant milestones has the company Elanco Animal Health achieved?

Elanco Animal Health Inc has achieved several significant milestones in its history. Since its inception, the company has focused on improving animal health through its innovative products and solutions. One major milestone was its spin-off from Eli Lilly and Company in 2018, establishing Elanco as a standalone company dedicated solely to animal health. Elanco has continually expanded its portfolio of products and services, helping to address the diverse needs of farmers and veterinarians worldwide. Through strategic acquisitions and collaborations, the company has strengthened its position in the animal health industry. Moreover, Elanco's commitment to sustainability and responsible animal care has garnered recognition, earning it a place among the industry leaders.

What is the history and background of the company Elanco Animal Health?

Elanco Animal Health Inc, a leading animal health company, has a rich history and background. Established in 1954 as a division of Eli Lilly and Company, Elanco has grown into a standalone company dedicated to improving animal health and well-being. With a wide portfolio of products and services, Elanco offers solutions for livestock and pets, encompassing pharmaceuticals, vaccines, and medicated feed additives. The company's commitment to innovation and research has positioned it as a global leader in animal health, addressing the evolving needs of the industry. Elanco Animal Health Inc continues to advance animal health through sustainable practices and partnerships, ensuring healthier and happier animals worldwide.

Who are the main competitors of Elanco Animal Health in the market?

The main competitors of Elanco Animal Health Inc in the market include Zoetis Inc, Merck Animal Health, and Boehringer Ingelheim.

In which industries is Elanco Animal Health primarily active?

Elanco Animal Health Inc is primarily active in the animal health industry.

What is the business model of Elanco Animal Health?

The business model of Elanco Animal Health Inc is focused on providing comprehensive solutions for animal health and welfare. Elanco develops and manufactures a wide range of pharmaceutical products, vaccines, and nutritional products for both companion animals and livestock. The company aims to improve the health and well-being of animals by delivering innovative solutions that enhance their productivity and quality of life. Elanco's business model operates through research and development, manufacturing, marketing, and sales of animal health products globally. With a commitment to innovation and sustainability, Elanco Animal Health is dedicated to supporting the welfare of animals and the needs of their owners.

What is the P/E ratio of Elanco Animal Health 2025?

The Elanco Animal Health P/E ratio is 12.25.

What is the P/S ratio of Elanco Animal Health 2025?

The Elanco Animal Health P/S ratio is 1.2.

What is the Quality Investing of Elanco Animal Health?

The Quality Investing for Elanco Animal Health is 3/10.

What is the revenue of Elanco Animal Health 2025?

The expected Elanco Animal Health revenue is 4.62 B USD.

How high is the profit of Elanco Animal Health 2025?

The expected Elanco Animal Health profit is 454.7 M USD.

What is the business model of Elanco Animal Health

Elanco Animal Health Inc. is a global company that focuses on researching, developing, manufacturing, and marketing products and solutions for animal health. The company offers a wide range of products in the areas of animal health, animal nutrition, and animal production, and serves customers in over 90 countries worldwide.

What is the Elanco Animal Health dividend?

Elanco Animal Health pays a dividend of 0 USD distributed over payouts per year.

How often does Elanco Animal Health pay dividends?

The dividend cannot currently be calculated for Elanco Animal Health or the company does not pay out a dividend.

What is the Elanco Animal Health ISIN?

The ISIN of Elanco Animal Health is US28414H1032.

What is the Elanco Animal Health WKN?

The WKN of Elanco Animal Health is A2N6BH.

What is the Elanco Animal Health ticker?

The ticker of Elanco Animal Health is ELAN.

How much dividend does Elanco Animal Health pay?

Over the past 12 months, Elanco Animal Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Elanco Animal Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Elanco Animal Health?

The current dividend yield of Elanco Animal Health is .

When does Elanco Animal Health pay dividends?

Elanco Animal Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Elanco Animal Health?

Elanco Animal Health paid dividends every year for the past 0 years.

What is the dividend of Elanco Animal Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Elanco Animal Health located?

Elanco Animal Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Elanco Animal Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Elanco Animal Health from 3/4/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/4/2025.

When did Elanco Animal Health pay the last dividend?

The last dividend was paid out on 3/4/2025.

What was the dividend of Elanco Animal Health in the year 2024?

In the year 2024, Elanco Animal Health distributed 0 USD as dividends.

In which currency does Elanco Animal Health pay out the dividend?

The dividends of Elanco Animal Health are distributed in USD.

All fundamentals about Elanco Animal Health

Our stock analysis for Elanco Animal Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elanco Animal Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.